Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (81-90 of 348) with videos related to

Pageof 35
Sort By:
Cancer Chemotherapy and Pharmacology|May 24, 2007
A late phase II study of S-1 for metastatic pancreatic cancerTakuji Okusaka, Akihiro Funakoshi, Junji Furuse, et al.
Japanese Journal of Clinical Oncology|July 16, 2010
Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805)Atsuo Takashima, Chigusa Morizane, Hiroshi Ishii, et al.
Surgical Case Reports|March 29, 2018
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case reportRyota Matsuki, Masanori Sugiyama, Hidefumi Takei, et al.
American Journal of Clinical Oncology|June 1, 2002
Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosisTatsuya Abe, Junji Furuse, Masahiro Yoshino, et al.
Anticancer Research|July 3, 2017
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 CasesNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 3, 2005
In vivo pressure estimation using subharmonic contrast microbubble signals: proof of conceptFlemming Forsberg, Ji-Bin Liu, William T Shi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2010
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron after chemotherapy including irinotecan]Shigeatsu Motoori, Yuko Hosokawa, Tomoe Miyazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[The Risk Factors of Cancer Chemotherapy in Elderly Patients]Eriko Nozaki, Satoko Maeno, Fumio Nagashima, et al.
Anticancer Research|March 2, 2018
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract CancerNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Cancer Science|August 14, 2015
Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, et al.
Pageof 35

Showing results (81-90 of 348) with videos related to

Sort By:
Pageof 35
Cancer Chemotherapy and Pharmacology|May 24, 2007
A late phase II study of S-1 for metastatic pancreatic cancerTakuji Okusaka, Akihiro Funakoshi, Junji Furuse, et al.
Japanese Journal of Clinical Oncology|July 16, 2010
Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805)Atsuo Takashima, Chigusa Morizane, Hiroshi Ishii, et al.
Surgical Case Reports|March 29, 2018
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case reportRyota Matsuki, Masanori Sugiyama, Hidefumi Takei, et al.
American Journal of Clinical Oncology|June 1, 2002
Clinical characteristics of hepatocellular carcinoma with an extensive lymph node metastasis at diagnosisTatsuya Abe, Junji Furuse, Masahiro Yoshino, et al.
Anticancer Research|July 3, 2017
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 CasesNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 3, 2005
In vivo pressure estimation using subharmonic contrast microbubble signals: proof of conceptFlemming Forsberg, Ji-Bin Liu, William T Shi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2010
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron after chemotherapy including irinotecan]Shigeatsu Motoori, Yuko Hosokawa, Tomoe Miyazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[The Risk Factors of Cancer Chemotherapy in Elderly Patients]Eriko Nozaki, Satoko Maeno, Fumio Nagashima, et al.
Anticancer Research|March 2, 2018
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract CancerNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Cancer Science|August 14, 2015
Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?Takuji Okusaka, Masafumi Ikeda, Akira Fukutomi, et al.
Pageof 35